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Research
Over the last 10 years epidemiologic stud-
ies have increasingly found higher daily mor-
bidity and mortality associated with acute 
changes in ambient particulate matter (PM) 
exposures [Pope and Dockery 1999; U.S. 
Environmental Protection Agency (EPA) 
2004]. These changes have been reported at 
concentrations at or near current ambient lev-
els and have raised concerns about the ade-
quacy of the National Air Quality Standards 
for PM in protecting human populations with 
an adequate margin of safety. Many of the 
early studies were criticized because mech-
anisms underlying the observed effects had 
not been elucidated at the time, particularly 
those related to cardiovascular morbidity and 
mortality. Recent toxicologic and human 
clinical studies have suggested a variety of 
PM-mediated mechanisms, including auto-
nomic nervous system responses, particularly 
among patients with preexisting cardiovascu-
lar diseases (Chuang et al. 2007; Zanobetti 
and Schwartz 2007).
Heart rate variability (HRV), which is 
under the control of the autonomic nervous 
system, has been demonstrated to vary with 
air pollution (Delfino et al. 2005; Gold et al. 
2000). Reduced HRV has been associated 
with increased risk of myocardial infarction 
in population studies (Tsuji et al. 1996) and 
has been considered a predictor of increased 
risk of mortality in patients with heart failure 
(Anonymous 1996). Although these studies 
did not assess the impact of acute changes 
in HRV, a recent study reported that isch-
emic events are preceded by decreases in 
high-frequency (HF) HRV in the hour before 
the event (Kop et al. 2001), and a decrease 
in HRV also has been reported to precede 
paroxysmal atrial fibrillation (Bettoni and 
Zimmermann 2002). Hence, short-term 
changes in HRV also may be risk factors for 
more serious consequences.
Local and regional traffic has been pro-
posed as an important source of PM pollu-
tion that may increase cardiovascular risk, 
perhaps through triggering short-term auto-
nomic changes. A recent German study dem-
onstrated that exposure to local traffic within 
the previous hour was a trigger of myocardial 
infarction, but the mechanism through which 
this occurred was not determined (Peters et al. 
2004). Traffic can be a source not only of PM 
pollution but also of stress, a known risk fac-
tor for adverse cardiac outcomes, and psycho-
logic stress has been known to influence HRV 
and autonomic function (Anderson et al. 
2007). In a study of traffic patrol troopers, 
traffic pollution inside the vehicle was dem-
onstrated to increase HRV, systemic inflam-
mation, and cardiac arrhythmias (Riediker 
et al. 2004). Most other studies have found 
reduction in HRV with pollution (Brook 
et al. 2004), but the directionality and clinical 
implications of the pollution-related cardiac 
autonomic changes likely vary with patient 
vulnerability.
With a specific focus on traffic pollution 
effects, we undertook a study of potentially sus-
ceptible patients with recent hospitalization for 
coronary artery disease to determine whether 
HRV was affected by ambient changes in PM 
pollution and a report of being in traffic.
Materials and Methods
Patient recruitment. The study design has 
been previously described (Chuang et al. 
2008). Briefly, before they were discharged, 
we recruited a panel of patients with doc-
umented coronary artery disease from the 
greater Boston, Massachusetts, area (within 
Route 495, a 40-km radius of our central 
monitoring site) who had undergone percu-
taneous coronary intervention for an acute 
coronary syndrome (acute myocardial infarc-
tion or unstable angina pectoris) or for stable 
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In t r o d u c t I o n: Ambient particulate pollution and traffic have been linked to myocardial infarction 
and cardiac death risk. Possible mechanisms include autonomic cardiac dysfunction.
Me t h o d s : In a repeated-measures study of 46 patients 43–75 years of age, we investigated asso-
ciations of central-site ambient particulate pollution, including black carbon (BC) (a marker for 
regional and local traffic), and report of traffic exposure with changes in half-hourly averaged heart 
rate variability (HRV), a marker of autonomic function measured by 24-hr Holter electrocardio-
gram monitoring. Each patient was observed up to four times within 1 year after a percutaneous 
intervention for myocardial infarction, acute coronary syndrome without infarction, or stable 
coronary artery disease (4,955 half-hour observations). For each half-hour period, diary data defined 
whether the patient was home or not home, or in traffic. 
re s u l t s: A decrease in high frequency (HF; an HRV marker of vagal tone) of –16.4% [95% con-
fidence interval (CI), –20.7 to –11.8%] was associated with an interquartile range of 0.3-µg/m3 
increase in prior 5-day averaged ambient BC. Decreases in HF were independently associated both 
with the previous 2-hr averaged BC (–10.4%; 95% CI, –15.4 to –5.2%) and with being in traffic 
in the previous 2 hr (–38.5%; 95% CI, –57.4 to –11.1%). We also observed independent responses 
for particulate air matter with aerodynamic diameter ≤ 2.5 µm and for gases (ozone or nitrogen 
dioxide).
co n c l u s I o n: After hospitalization for coronary artery disease, both particulate pollution and being 
in traffic, a marker of stress and pollution, were associated with decreased HRV.
Key w o r d s : air pollution, cardiac event, heart rate variability, myocardial infarction, traffic. 
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coronary artery disease with worsening symp-
toms, between October 1999 and January 
2003. The presence of an acute myocardial 
infarction was defined as an elevation in cre-
atine kinase (CK), CK-MB, or troponin I 
levels greater than three times the upper limit 
of normal in the setting of typical chest pain 
and electrocardiogram (ECG) changes. The 
diagnosis of prior myocardial infarction was 
extracted from the patients’ hospital record. 
We excluded those with atrial fibrillation 
and left bundle branch block because of the 
intent to evaluate HRV as well as ST-segment 
depression as outcomes. Coronary artery 
bypass graft surgery within the preceding 
3 months was an exclusion criterion because 
the nonspecific ST and T-wave changes post-
operatively would preclude accurate inter-
pretation of new ST and T-wave changes. 
Patients with psychiatric illness or drug abuse 
problems were excluded because of compli-
ance and reliability issues. Active cigarette 
smoking was an exclusion criterion at entry to 
the study, and no participant reported current 
smoking at the time of recruitment. Although 
four subjects reported recidivist smoking, each 
reported smoking at only one visit, and only 
one reported > 0–1 cigarettes per day at that 
visit (Table 1).
Study protocol. The protocol included 
a home visit within 2–4 weeks after hospi-
tal discharge, followed by three additional 
follow-up visits at approximately 3-month 
intervals. At the first visit, a baseline screen-
ing questionnaire was administered regarding 
medications, pulmonary and cardiac symp-
toms, and smoking history.
Three-lead 24-hr Holter ECG moni-
toring (Marquette Seer Digital Recorder; 
Marquette Inc., Milwaukee, WI) was also 
performed with electrodes in modified V5 
and aVF positions. During this monitor-
ing, participants completed a standardized 
diary defining their activities and location 
for each half-hour period. For subsequent 
visits, participants were administered a brief 
questionnaire regarding cardiac and respi-
ratory symptoms and medication use, and 
then received 24-hr Holter monitoring. We 
obtained written informed consent from the 
study subjects. The study design was reviewed 
and approved by the human subjects commit-
tees of the Brigham and Women’s Hospital 
and the Harvard School of Public Health.
Digitized Holter monitor recordings 
were analyzed using a Marquette MARS 
Workstation (GE Medical Systems, Milwaukee, 
WI). Tracings were initially reviewed for arti-
fact by a trained technician. HRV was assessed 
using conventional time domain and frequency 
domain variables, measured using validated 
software (Anonymous 1996). Two patients 
on continuous positive airway pressure for 
sleep apnea were excluded from data analysis 
because of the potential influence of positive 
pressure on HRV outcomes. Time domain 
variables included the standard deviation of 
normal-to-normal heart beat intervals (SDNN) 
and the square root of the mean of the squared 
differences between adjacent normal RR inter-
vals (r-MSSD). These values were averaged 
over 30-min clock time intervals to correspond 
with the resolution of the aerometric measures, 
which were collected over 30-min intervals. 
Frequency domain variables included HF mea-
sures and total power (TP). Both r-MSSD and 
HF were used to provide a measure of vagal 
activity, whereas SDNN and TP were used 
to provide a measure of sympathovagal activ-
ity. To our knowledge there are no validated 
criteria for half-hour HRV measures to define 
outliers. We therefore chose to use three times 
the median of the absolute differences as the 
cutoff for outliers. This resulted in a loss of 
approximately 13% of each of the HRV meas-
ures used in the analysis.
Information about diabetes diagnosis was 
abstracted from the medical records.
From diary data, the location of each par-
ticipant was determined for each half-hour 
period, with location noted as home or not 
home, and in traffic defined as driving or rid-
ing in a car or riding a bus, subway, or train. 
For each 30-min interval, we classified each 
subject as in traffic in the previous 2 hr, not 
in traffic in the previous 2 hr, or in traffic part 
of the previous 2 hr. We similarly classified 
the subjects in relation to being home.
Analyses examined the association 
between HRV measures and both lagged and 
accumulated averages of ambient exposures to 
fine PM [≤ 2.5 µm in aerodynamic diameter 
(PM2.5)] and black carbon (BC) for periods 
ranging between 30 min to a few hours and 
up to 5 days preceding the HRV measures.
Aerometrics. Ambient PM concentra-
tions were measured at a central monitor-
ing site located on the roof of Countway 
Library, Harvard Medical School, in down-
town Boston for the years 1999 to 2003. 
The median distance of participant homes 
from the central site monitoring station was 
17.6 km. Ambient measures included con-
tinuous PM2.5 concentrations measured using 
a tapered element oscillation microbalance 
(TEOM) (model 1400A; Rupprecht and 
Pastashnick, East Greenbush, NY) with a 
2.5-µm (PM2.5) cut point. Ambient BC was 
measured using an aethalometer (model 8021; 
McGee Scientific, Berkeley, CA).
Hourly measurements of carbon mon-
oxide (CO), ozone (O3), nitrogen diox-
ide (NO2), and sulfur dioxide (SO2) were 
obtained by taking the mean of site values 
for each gas from state monitoring sites in 
Boston: five sites for NO2 and SO2, four sites 
for CO, and three sites for O3. PM2.5 and BC 
and the gases concentrations were summarized 
in half-hour intervals and as running aver-
ages from 0.5 hr up to and including 120 hr 
(5-day moving averages).
Indoor PM2.5 was measured inside the 
homes of participants continuously using a 
TEOM with each measurement integrated 
over periods of half-hour, whereas indoor BC 
was measured using the aethalometer. BC was 
measured also outside the participants’ homes 
(called outdoor BC from now on). Hourly 
temperature was obtained from the National 
Weather Service first-order station at Logan 
Airport.
Statistical analysis. We analyzed the 
association of HRV with air pollution using 
generalized additive fixed-effect regression 
  models—that is, we included an indicator vari-
able for each subject. This takes into account 
the effect of the within-subject similarities due 
to repeated measurements within each subject 
and removes the potential for confounding of 
subject-specific (time-  invariant) factors (Hastie 
and Tibshirani 1990). In addition to control-
ling for each subject, the models also controlled 
for day of the week with indicator variables; for 
traffic; and for average heart rate, hour of the 
day, date, and mean temperature with penalized 
Table 1. Participant characteristics (n = 46) fol-
lowed up after an acute coronary event.
Characteristic Median (range) n (%)
Age (years) 57 (43–75)
r-MSSD (msec) 25.3 (6.8–83.5)
SDNN (msec) 66.8 (11.7–147.7)
HF (msec2) 90.5 (0.2–1,235)
TP (msec2) 4,381 (125.1–21,650)
Sex
Male 37 (80.4)
Female 9 (19.6)
No. of visits
1 45 (36.0)
2 34 (27.2)
3 24 (19.2)
4 22 (17.6)
Total 125 (100)
Diagnosis
Myocardial infarction current 18 (39.1)
Coronary artery disease, not myocardial 
infarction 
28 (60.9)
Ever used medication
Statin 42 (91.3)
Aspirin 41 (89.1)
Beta blocker 42 (91.3)
Calcium channel blocker 5 (10.9)
Angiotensin-converting enzyme inhibitors 24 (52.2)
Asthma: theophylline and beta antagonist 2 (4.3)
Digoxin 2 (4.3)
Diabetes
No 35 (76.1)
Yes 11 (23.9)
Cigarette smoking
Never 15 (32.6)
Former 27 (58.7)
Current 4 (8.7)
Ethnic group
White 43 (93.5)
Black 1 (2.2)
Asian and other 2 (4.3)Zanobetti et al.
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splines with 4, 6, 12, and 4 degrees of freedom 
(df), respectively. Results were not sensitive to 
changing the number of degrees of freedom for 
temperature and seasonality. Relative humidity 
was not a significant predictor.
Traffic was defined as a categorical variable 
as being in traffic in the previous 2 hr, not in 
traffic in the previous 2 hr, or in traffic part 
of the previous 2 hr. To eliminate concur-
vity between the penalized splines of date and 
temperature, we first regressed temperature 
against a penalized spline of date. We used 
the residuals from this model to control for 
temperature in our model for HRV. The out-
come variables were log-transformed to meet 
normality assumptions. We assessed the rela-
tionship between ambient pollutant and HRV 
overall and for selected repeated time periods 
after acute hospitalization. The HRV mea-
surements were analyzed with and without 
heart rate adjustment. To take into account 
correlation between adjacent half-hours, we 
used 6 df in the smoothing function of hour 
of the day. We checked the assumption of 
linear dose–response relationships used in the 
analyses. The analyses were performed using 
the statistical package R (R Development 
Core Team 2009). 
In secondary analyses we assessed the 
effect modification by including an interac-
tion term, with discharge diagnoses and his-
tory of diabetes. We also examined whether 
the previous 2-hr associations varied accord-
ing to whether a subject was home for the 
previous 2 hr, not home during this time, or 
home only part of the 2 hr.
Results are presented as percent change 
scaling the PM2.5 effects and BC effects to the 
25th to 75th interquartile range (IQR) for 
each pollutant at each averaging time period.
Results
We enrolled 46 subjects, whom we studied 
in their homes on up to four occasions dur-
ing the course of 1 year after their index event 
(Table 1). The subjects, all of whom had doc-
umented coronary artery disease, ranged in 
age from 43 to 75 years, approximately 80% 
were males, and all but three were Caucasian. 
Eighteen (39%) of the subjects experienced 
an acute myocardial infarction as part of the 
index hospitalization. Of the remaining 28 
without an acute myocardial infarction, 18 
(64%) had a history of previous myocardial 
infarction. Almost all participants were on sta-
tins, aspirin, and beta blockers. Approximately 
half of the patients (24) also were treated 
with angiotensin-converting enzyme inhibi-
tors, with all other drugs being used by < 15% 
of the subjects. Participants with more than 
one follow-up visit were on average younger 
than participants with only one visit (57 vs. 62 
years old) and were less likely to have ever had 
a myocardial infarction, although this differ-
ence was not statistically significant (Table 1). 
For the 46 subjects, we obtained 125 sepa-
rate 24-hr ECG Holter recording sessions, 
with 4,955 half-hour observations. We had 
3,179 observations for indoor PM2.5, 3,365 
for indoor BC, and 2,508 for outdoor BC.
Ambient pollution levels were relatively 
low, with PM2.5 and gases never exceeded 
the current or proposed National Air Quality 
Standards (U.S. EPA 2004). However, the dis-
tribution of both ambient PM2.5 and BC con-
centrations during the study periods exhibited 
substantial variability, as evidenced by IQRs 
corresponding to an approximately 2.5-fold 
difference in concentrations. Pollutant vari-
ability was greatest for the shorter exposure 
periods (up to 4 hr). For the longer 3–5 day 
average concentrations, IQRs differed by 1- 
to 2-fold (Table 2). When assessing indoor 
pollution, indoor PM2.5 concentrations were 
slightly lower compared with the ambient, 
whereas the indoor BC concentrations were 
half those observed for the ambient BC. Ten 
subjects for a total of 17 of 125 visits reported 
very occasional smoking by other adults in 
the home “since we last saw you.” The mean 
levels for either BC or PM were slightly but 
not significantly higher for observations when 
smoking was reported versus when it was not 
(14 vs. 11 µg/m3 for PM half-hourly average).
Ambient pollution and HRV. Using 
ambient concentrations as the exposure 
meas  ure, we found significant negative asso-
ciations between both r-MSSD and HF and 
both PM2.5 and BC for all averaging periods. 
Overall, we observed a tendency for decreases 
to be larger with longer averaging times 
(Figure 1). For example, for PM2.5, at 1 hr 
for an IQR of 8.2 µg/m3 compared with the 
5-day IQR average of 4.8 µg/m3, the decrease 
in r-MSSD was –1.47% [95% confidence 
interval (CI), –2.53 to –0.4%] versus –3.1% 
(95% CI, –4.35 to –1.85%). Effects of PM 
pollutants on percent change for HF were 
greater in magnitude than for r-MSSD across 
all the time periods examined (Figure 1), with 
a decrease in HF of –4.4% (95% CI, –7.6 to 
–1.15%) for an IQR increase in PM2.5 the 
previous hour and a decrease of –6.9% (95% 
CI, –10.5 to –3.1%) for an IQR increase 
in the 5-day moving average of PM2.5. The 
effects were even larger in association with BC 
with a decrease in HF of –16.4% (95% CI, 
–20.7 to –11.8%) for an IQR of 0.3-µg/m3 
increase in BC for the 5-day moving average. 
In contrast, for all subjects taken together, the 
Table 2. Distribution of air pollution and weather variables for all subjects (n = 46).
Percentile
Variable 5th 25th 50th 75th 95th IQR
Mean temperature (°C)  –6.1 3.3 10 18.9 27.8
Ambient pollution
PM2.5 (µg/m3)
30 min 1.96 5.44 9.06 13.66 25.54 8.34
2-hr mean 2.54 5.65 8.92 13.58 25.07 7.93
72-hr mean 4.72 7.16 9.93 12.65 19.31 5.50
120-hr mean 5.48 7.6 9.54 12.34 15.95 4.83
BC (µg/m3)
30 min 0.2 0.41 0.69 1.04 1.9 0.62
2-hr mean 0.22 0.42 0.70 1.03 1.83 0.61
72-hr mean 0.38 0.59 0.80 1.07 1.41 0.48
120-hr mean 0.43 0.59 0.74 0.93 1.16 0.34
NO2 (ppm)
30 min 0.011 0.017 0.021 0.027 0.036 0.011
2-hr mean 0.011 0.017 0.021 0.027 0.036 0.010
72-hr mean 0.015 0.018 0.021 0.025 0.031 0.007
120-hr mean 0.015 0.018 0.021 0.024 0.029 0.006
O3 (ppb)
30 min 2.04 11.36 20.73 30.33 53.96 18.97
2-hr mean 2.29 11.34 20.47 30.08 54.29 18.74
72-hr mean 7.95 15.71 21.87 28.33 42.33 12.62
120-hr mean 9.66 16.72 22.75 29.28 38.72 12.56
Indoor pollution
PM2.5 (µg/m3)
30 min 1.39 4.46 7.88 12.41 31.17 7.95
2-hr mean 1.84 4.68 8.16 12.56 31.98 7.88
4-hr mean 2.01 4.88 8.43 12.79 30.3 7.91
BC (µg/m3)
30 min 0.1 0.21 0.38 0.62 1.17 0.41
2-hr mean 0.11 0.22 0.39 0.62 1.14 0.4
4-hr mean 0.11 0.22 0.4 0.63 1.12 0.41
Outdoor “at home” BC (µg/m3)
30 min 0.11 0.25 0.47 0.78 1.42 0.52
2-hr mean 0.11 0.26 0.49 0.77 1.38 0.51
4-hr mean 0.12 0.28 0.49 0.78 1.29 0.5Air pollution, traffic, and heart rate variability
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associations noted over the same time periods 
for SDNN and TP were smaller and were sig-
nificant only in association with BC at short 
lags (Figure 1).
Previously we reported that those with 
diabetes had greater ST-segment depression 
with air pollution exposures (Chuang et al. 
2008). Similarly, although we saw effects 
of pollution on HRV for people with and 
without diabetes by means of an interaction 
term, those with diabetes exhibited the larg-
est response to pollution. For example, for a 
3-day moving average of PM2.5, the decrease 
in r-MSSD was –0.9% (95% CI, –2.1 to 
0.3%) in those without diabetes versus –9.5% 
(95% CI, –12.5 to –6.5%) in subjects with 
diabetes. For a 3-day moving average of BC, 
the decrease in r-MSSD was –3.2% (95% 
CI, –5.0 to –1.3%) in those without diabetes 
and –9.1% (95% CI, –13.2 to –4.9%) in 
those with diabetes. However, in contrast to 
our report on the outcome of ST-segment 
depression (Chuang et al. 2008), those with-
out myocardial infarction but with unstable 
angina pectoris or worsening stable coronary 
artery disease showed a stronger effect of PM 
on HRV than did those with a discharge diag-
nosis of myocardial infarction. For a 3-day 
moving average of PM2.5, the decrease in 
r-MSSD was –2.9% (95% CI, –4.3 to –1.6%) 
for those without myocardial infarction but 
with unstable angina pectoris or worsening 
stable coronary artery disease versus 0.3% 
(95% CI, –1.8 to 2.4%) for those with myo-
cardial infarction. For a 3-day moving average 
of BC, the decrease in r-MSSD was –5.9% 
(95% CI, –7.9 to –3.9%) for those with-
out myocardial infarction but with unstable 
angina pectoris or worsening stable coronary 
artery disease, and –0.4% (95% CI, –3.1 to 
2.4%) for those with a myocardial infarction. 
The interaction for diagnosis of diabetes and 
myocardial infarction was always significant, 
with a p-value < 0.001. Because > 90% of our 
patients were consistently taking statins and 
beta blockers throughout the study, we could 
not evaluate whether these medications were 
protective against pollution effects.
Indoor pollution and HRV. Table 3 and 
Figure 2 present the effects of indoor com-
pared with outdoor pollution measures on 
HRV, and the effects of ambient pollution 
when a subject was at home versus away from 
home. Because there were more ambient 
than indoor observations, for comparability 
of results in Figure 2, we present the indoor, 
outdoor, and ambient results from the data 
set with the same number of observations for 
both indoor and ambient. Table 3 focuses 
on the more immediate effects of pollution, 
because we wanted to evaluate cumulative pol-
lution exposures during a period comparable 
with time spent in traffic (2 hr), or to time 
spent at home, given that most participants 
left the house for portions of the day.
The percent changes in Figure 2 and 
Table 3 are scaled to 10 µg/m3 for PM2.5 and 
to 1 µg/m3 for BC. We found no significant 
effects of pollution on HRV when the subjects 
were home, either for ambient or for indoor 
measured pollution. When subjects were home 
part of the time, the magnitude of the associa-
tion of ambient pollution with reduced HRV 
was larger than when they were home all of 
the time, but smaller than when they were 
away from home all of the time. For example, 
when the patients were away from home dur-
ing the previous 2 hr, we found a 7.9% (95% 
CI, –10.3 to –5.3%) decrease in r-MSSD for a 
10-µg/m3 increase in PM2.5 and a 6.9% (95% 
CI, –10.1 to –3.6%) decrease for a 1-µg/m3 
increase in BC, compared with a 0.4% (95% 
CI, –1.3 to 2.1%) decrease and a 0.45% (95% 
CI, –1.8 to 2.8%) decrease, respectively, when 
the patients were home. We also found a 
14.8% (95% CI, –21.6 to –7.4%) decrease 
in HF for a 10-µg/m3 increase in PM2.5 and a 
17.4% (95% CI, –25.9 to –8%) decrease for 
a 1-µg/m3 increase in BC when the patients 
were away from home during the previous 
2 hr, compared with a 1.6% (95% CI, –6.6 to 
3.6%) decrease and a 5.2% (95% CI, –11.7 to 
1.7%) decrease, respectively, when the patients 
were home.
Traffic and HRV. We defined traffic as 
driving or riding in a car or riding a bus, sub-
way, or train; cars were the mode of transport 
for 90% of the observations for time in traffic. 
Traffic exposure in the previous 2 hr had the 
largest effect on reduction of HRV, which was 
independent of the effects of ambient cen-
tral site–measured BC (Table 3). Traffic was 
associated with a 15% decrease in r-MSSD 
and a 39% decrease in HF. We found a dose–
response relationship: When the patients were 
in traffic only part of the previous 2 hr, traffic 
exposure was associated with a 3% decrease in 
r-MSSD and a 5% decrease in HF.
Ambient gases and HRV. We found 
decreases in r-MSSD for all averaging time 
of O3 with a 2.1% (95% CI, –3.5 to –0.6%) 
decrease for an IQR increase of 19 ppb mean 
O3 in the previous 2 hr and a 3.4% (95% CI, 
–5.2 to –1.5%) decrease for an IQR increase 
Figure 1. Percent change (95% CI) in r-MSSD (msec; A), SDNN (msec; B), HF (msec2; C), and TP (msec2; D) associated with different averaging times of PM2.5 and 
BC exposure. MA, moving average. PM2.5 and BC effects are scaled to their IQR. 
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of 13 ppb in the 5-day moving average of 
O3 (Figure 3). HF was not associated with 
O3 but was associated with NO2 for all aver-
aging times. The association between NO2 
and HF was relatively large and consistent 
across all averaging times, with a decrease of 
6.7% (95% CI, –10.8 to –2.5%) for an IQR 
increase of 0.011 ppm in the 2-hr average 
NO2, and a decrease of 9.4% (95% CI, –14.1 
to –4.4%) for an IQR increase of 0.006 ppm 
in the 5-day average of NO2.
The correlation between the gases and 
PM2.5 and BC was only modest, with a cor-
relation for the 72-hr average PM2.5 of 0.46 
with NO2 and 0.29 with O3; the correlation 
of BC for the 72-hr average was 0.46 with 
NO2 and –0.08 with O3.
We tested two-pollutant models using 
each of the gas and PM measures together 
(Table 4). For both r-MSSD and HF and for 
both PM2.5 and BC, the addition of O3 or 
NO2 to the model did not significantly alter 
the effects seen in the single-pollutant models. 
Both O3 and PM2.5 had independent effects 
on reduced HF.
Discussion
These results suggest that short-term traffic 
exposure and ambient exposure to air pol-
lution are associated with significant reduc-
tions in HRV in free-living patients with 
underlying heart disease, and that recent traf-
fic exposure can cause reductions in HRV 
as great as 39% in patients 2–6 weeks after 
hospitalization for coronary artery disease. As 
in previous studies (Adar et al. 2007b; Gold 
et al. 2000; Schwartz et al. 2005), we found 
stronger autonomic dysfunction for HRV 
measures that represent vagal tone (r-MSSD 
and HF) than for HRV measures representing 
overall autonomic responses or sympathetic 
tone (SDNN and TP). We found associations 
for both at shorter (2 hr) as well as at longer 
averaging times (up to 5 days). We observed 
the greatest effects of PM and BC for longer 
cumulative averages.
We may not have found an influence of 
indoor air pollution on HRV because the 
indoor levels were lower, with few indoor 
sources of indoor pollution. However, in this 
same cohort, we did find an effect of both out-
door and indoor BC on increases in T-wave 
alternans (Zanobetti et al. 2009), an electro-
physiologic measure of alternating repolari-
za  tion waveform indicative of instabilities in 
cardiac membrane voltage and disruptions 
in intracellular calcium cycling dynamics. In 
our cohort, the T-wave alternans was more 
influenced by short-term cumulative averages 
of pollution and may be linked to pollution 
exposure through pathways different from 
those of HRV. Pollution may influence HRV 
through direct stimulation of pulmonary 
Figure 2. Percent change (95% CI) in r-MSSD (msec) associated with different averaging times of indoor PM2.5 
and BC exposure. MA, moving average. PM2.5 and BC effects are scaled to 10 and 1 µg/m3, respectively.
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Table 3. Percent change in r-MSSD and HF for ambient and indoor PM2.5 and BC: effects of control for 
traffic exposure on the association with ambient PM and effect modification. 
Percent change (95% CI)
Exposure r-MSSD HF
Models including ambient PM2.5
Model 1 2-hr mean ambient PM2.5 –2.0 (–3.3 to –0.6) –5.2 (–9.2 to –1.1)
In traffic, previous 2 hr –15.2 (–24.8 to –4.4) –39.2 (–58.0 to –12.0)
In traffic, part of the previous 2 hr –2.8 (–5.4 to –0.2) –4.8 (–12.4 to 3.4)
Model 2 2-hr mean ambient PM2.5 –2.2 (–3.6 to –0.9) –5.9 (–9.8 to –1.8)
Model 3 2-hr mean ambient PM2.5, not home –7.9 (–10.3 to –5.3) –14.8 (–21.6 to –7.4)
2-hr mean ambient PM2.5, home 0.4 (–1.3 to 2.1) –1.6 (–6.6 to 3.6)
2-hr mean ambient PM2.5, home part of time –4.0 (–7.0 to –0.9) –9.3 (–17.8 to 0.0)
Models including indoor PM2.5 at home
Model 4 30-min mean indoor PM2.5 0.2 (–0.8 to 1.3) –0.8 (–4.0 to 2.5)
Model 5 2-hr mean indoor PM2.5 0.0 (–1.1 to 1.2) –1.3 (–4.9 to 2.5)
Models including ambient BC
Model 1 2-hr mean ambient BC –2.2 (–4.0 to –0.4) –10.4 (–15.4 to –5.2)
In traffic, previous 2 hr –15.7 (–25.2 to –5.0) –38.5 (–57.4 to –11.1)
In traffic, part of the previous 2 hr –2.9 (–5.5 to –0.3) –4.9 (–12.5 to 3.3)
Model 2 2-hr mean ambient BC –2.5 (–4.3 to –0.7) –11.1 (–15.9 to –5.9)
Model 3 2-hr mean ambient BC, not home –6.9 (–10.1 to –3.6) –17.4 (–25.9 to –8.0)
2-hr mean ambient BC, home 0.4 (–1.8 to 2.8) –5.2 (–11.7 to 1.7)
2-hr mean ambient BC, home part of time –6.5 (–10.2 to –2.6) –22.2 (–31.5 to –11.6)
Models including indoor BC at home
Model 4 30-min mean indoor BC 2.1 (0.0 to 4.2) 2.1 (–4.3 to 8.8)
Model 5 2-hr mean indoor BC 2.0 (–0.2 to 4.4) 2.3 (–4.7 to 9.8)
Each model evaluates air pollution using different metrics of exposure as listed in the table. All models adjust for sub-
ject and day of the week, average heart rate, hour of the day, date, and mean temperature as described in the text. For 
example, model 2 has a term for 2-hr mean ambient BC but does not include the three-level traffic variable. PM2.5 and BC 
effects are scaled to 10 and 1 µg/m3, respectively.
Figure 3. Percent change (95% CI) in r-MSSD (msec; A) and HF (msec2; B) associated with different averaging times of O3 and NO2 exposure. MA, moving aver-
age. O3 and NO2 effects are scaled to their IQR.
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reflexes, leading to cardiac or systemic auto-
nomic dysfunction, or through pulmonary/
systemic inflammation or oxidative stress, 
which may lead to autonomic dysfunction 
(Adamkiewicz et al. 2004; Adar et al. 2007a; 
Chuang et al. 2007; Park et al. 2005; Peters 
et al. 2006).
The associations of ambient (central 
site–measured) BC with our outcomes were 
uniformly stronger than the associations of 
BC outside the home with our outcomes 
(Figure 2). It is possible that ambient central 
site measures of BC had stronger and larger 
associations with reduced HRV than did out-
door “outside the home” measures because 
our ambient measures provide a better mea-
sure of regional average exposure during the 
times when our participants were away from 
home. The association of reduced HRV in 
single-pollutant models with only NO2, 
which can be considered another marker of 
traffic in addition to BC, provides further 
support for the effects of pollution of traffic 
origins. The data also suggest that mixtures of 
pollutions may influence autonomic cardiac 
tone, in that both PM pollution and O3 had 
independent associations with reduced HRV 
in two-pollutant models.
Our results are consistent with the previ-
ous literature on potentially high-risk patients, 
defined as elderly subjects (with or without 
documented coronary heart disease) (Creason 
et al. 2001; Gold et al. 2000; Holguin et al. 
2003; Liao et al. 2004; Pope et al. 2004). 
Others have studied pollution responses in 
patients with stable coronary heart disease 
(Lipsett et al. 2006; Timonen et al. 2006), 
whereas we studied our subjects 2–6 weeks 
after hospitalization for myocardial infarc-
tion, unstable angina pectoris, or worsening 
stable coronary artery disease. Autonomic 
dysfunction can precede more serious cardiac 
electrophysiologic disturbances in vulnerable 
patients (Lombardi et al. 2000; Monmeneu 
et al. 2001; Shusterman et al. 2000). HRV 
is a predictor of long-term cardiac mortality 
(de Bruyne et al. 1999), although the debate 
continues as to whether it is a marker or cause 
of increased cardiac risk. Previously we have 
described pollution-associated ST-segment 
depression (Chuang et al. 2008) and increases 
in T-wave alternans (Zanobetti et al. 2009) 
in the subjects participating in our study; the 
finding of traffic- and pollution-associated 
autonomic dysfunction adds to the evidence 
that pollution is increasing cardiac risk in this 
vulnerable population.
Within this population that was vulner-
able on the basis of coronary artery disease, 
people with diabetes were even more vulner-
able. This adds to cumulative evidence that 
type 2 diabetes, which is accompanied by a 
chronic inflammatory state and by chronic 
autonomic dysfunction, is a source of vulner-
ability to pollution (Dubowsky et al. 2006; 
O’Neill et al. 2005, 2007; Zanobetti and 
Schwartz 2001, 2002).
The major limitation of this study, besides 
the relatively small number of study partici-
pants, was that we did not study all subjects 
on all occasions. In addition, although the 
strongest associations of HRV related to the 
previous 3 days’ ambient PM exposures, 72-hr 
integrated indoor or personal exposure mea-
surements were not available for comparison 
hours. More minor limitations relate to the 
self-report of medication use, without substan-
tial documentation of compliance. The find-
ing that increasing length of averaging times 
was associated with increasing effects could 
relate either to increasing biologic cumulative 
effects over time or to less measurement error 
over longer averaging periods. However, in 
this study we had better estimates of exposure 
than in most air pollution health effects studies 
using administrative data only. Although it is 
possible that our results could reflect time spent 
indoors at home immediately after hospitaliza-
tion or time spent sleeping, we did not find 
that either of these factors modified the effects 
of indoor pollution on HRV. For the few sub-
jects with environmental tobacco smoke (ETS) 
exposure in the home “since we last saw you,” 
it is possible that the indoor PM levels were, in 
part, due to ETS rather than ambient pollu-
tion penetrating indoors, cooking, or cleaning. 
However we found no association of indoor 
PM levels with reduced HRV with or without 
the observations where there was ETS in the 
home “since we last saw you.”
Although it is possible that being in traf-
fic represents a combination of exposures, 
we have confidence that the effects of traffic 
are not a result of chance or the specific vul-
nerability of a few subjects. Being in traffic 
for either part or all of the 2 hr before and 
including HRV measurement was associated 
with reduced HRV. Although we have only 
27 observations for 6 subjects who were in 
traffic for a full 2 hr, 40 subjects contributed 
315 observations when they were in traffic 
for part of the previous 2 hr (at least one half-
hour). It is, however, possible that being in 
traffic is a measure of a combination of factors 
with adverse effects. Studies have suggested 
that stress can trigger adverse cardiac events, 
including myocardial infarction or arrhyth-
mias (Albert et al. 2007). A limitation of our 
study is that we did not measure stress while 
in traffic and therefore cannot disentangle the 
combination of pollution and stress exposures 
that “being in traffic” represents. Nevertheless, 
in the models including “being in traffic” and 
in the models stratified by being indoors and 
not in traffic, the independent associations 
of measured pollution with reduced HRV 
are not likely to be confounded by the stress 
of being in traffic. We did not have details 
on pollution levels in the cars of our study 
participants. Ventilation in vehicles can vary 
widely. It would be useful for future studies 
to evaluate whether reduction of in-vehicle 
pollution improves HRV and other indicators 
of cardiac risk in vulnerable populations. 
This study provides further evidence 
that exposure to ambient pollution to both 
PM2.5 and BC alters autonomic function, 
particularly among subjects with a history of 
previous myocardial injury. Traffic exposure, 
which likely represents a complex combina-
tion of local pollution exposure and stress, 
independently adds to risk incurred by the 
background of regional pollution. Mixtures 
with gases such as O3 may add to the risk of 
PM pollution exposure. Susceptible popula-
tions such as individuals with coronary artery 
disease should be considered when setting 
national policies and regulations to control 
levels of PM air pollution and traffic.
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